Should I Buy Alcoa Stock?
Alcoa (AA) finds itself in an interesting position in early…
Buy
60
JWN Quote, Financials, Valuation and Earnings
Last price:
$24.47
Seasonality move
:
4.8%
Day range:
$24.42 - $24.47
52-week range:
$17.21 - $24.99
Dividend yield:
3.11%
P/E ratio:
14.22x
P/S ratio:
0.27x
P/B ratio:
3.58x
Volume:
1.7M
Avg. volume:
2.5M
1-year change:
21.33%
Market cap:
$4.1B
Revenue:
$15B
EPS (TTM):
$1.72
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Revenue | $10.7B | $14.8B | $15.5B | $14.7B | $15B | |
| Revenue Growth (YoY) | -30.98% | 38.02% | 5.01% | -5.39% | 2.2% | |
| Cost of Revenues | $7.6B | $9.3B | $10B | $9.3B | $9.4B | |
| Gross Profit | $3.1B | $5.4B | $5.5B | $5.4B | $5.6B | |
| Gross Profit Margin | 29.07% | 36.82% | 35.49% | 36.68% | 37.43% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $4.2B | $5B | $5B | $4.9B | $5.1B | |
| Other Inc / (Exp) | -- | -- | -- | -$284M | -- | |
| Operating Expenses | $4.2B | $5B | $5B | $4.9B | $5.1B | |
| Operating Income | -$1B | $492M | $465M | $535M | $495M | |
| Net Interest Expenses | $181M | $246M | $128M | $104M | $102M | |
| EBT. Incl. Unusual Items | -$1.2B | $246M | $337M | $147M | $393M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$538M | $68M | $92M | $13M | $99M | |
| Net Income to Company | -$690M | $178M | $245M | $134M | $294M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$690M | $178M | $245M | $134M | $294M | |
| Basic EPS (Cont. Ops) | -$4.39 | $1.12 | $1.53 | $0.83 | $1.79 | |
| Diluted EPS (Cont. Ops) | -$4.39 | $1.10 | $1.51 | $0.82 | $1.74 | |
| Weighted Average Basic Share | $157.2M | $159M | $160.1M | $161.8M | $164.3M | |
| Weighted Average Diluted Share | $157.2M | $162.5M | $162.1M | $163.4M | $168.9M | |
| EBITDA | -$205M | $1.3B | $1.3B | $1.1B | $1.3B | |
| EBIT | -$1B | $493M | $475M | $284M | $528M | |
| Revenue (Reported) | $10.7B | $14.8B | $15.5B | $14.7B | $15B | |
| Operating Income (Reported) | -$1B | $492M | $465M | $535M | $495M | |
| Operating Income (Adjusted) | -$1B | $493M | $475M | $284M | $528M | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.6B | $4.5B | $4.3B | $4.4B | $4.3B | |
| Revenue Growth (YoY) | -19.66% | 23.07% | -3.72% | 2.34% | -2.17% | |
| Cost of Revenues | $2.4B | $2.7B | $2.8B | $2.8B | $2.6B | |
| Gross Profit | $1.3B | $1.8B | $1.5B | $1.6B | $1.7B | |
| Gross Profit Margin | 35.12% | 39.86% | 34.99% | 36.31% | 39.04% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.3B | $1.5B | $1.3B | $1.4B | $1.4B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $1.3B | $1.5B | $1.3B | $1.4B | $1.4B | |
| Operating Income | $30M | $299M | $187M | $216M | $243M | |
| Net Interest Expenses | $48M | $33M | $27M | $26M | $23M | |
| EBT. Incl. Unusual Items | -$18M | $266M | $160M | $190M | $220M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$51M | $66M | $41M | $56M | $54M | |
| Net Income to Company | $33M | $200M | $119M | $134M | $166M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $33M | $200M | $119M | $134M | $166M | |
| Basic EPS (Cont. Ops) | $0.21 | $1.26 | $0.75 | $0.83 | $1.00 | |
| Diluted EPS (Cont. Ops) | $0.21 | $1.23 | $0.74 | $0.82 | $0.97 | |
| Weighted Average Basic Share | $157.8M | $159.3M | $160.1M | $162.7M | $165.2M | |
| Weighted Average Diluted Share | $157.8M | $173.3M | $161.5M | $169.1M | $171.3M | |
| EBITDA | $241M | $483M | $392M | $433M | $436M | |
| EBIT | $33M | $300M | $197M | $225M | $254M | |
| Revenue (Reported) | $3.6B | $4.5B | $4.3B | $4.4B | $4.3B | |
| Operating Income (Reported) | $30M | $299M | $187M | $216M | $243M | |
| Operating Income (Adjusted) | $33M | $300M | $197M | $225M | $254M | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Revenue | $10.7B | $14.8B | $15.5B | $14.7B | $15B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $7.6B | $9.3B | $10B | $9.3B | $9.4B | |
| Gross Profit | $3.1B | $5.4B | $5.5B | $5.4B | $5.6B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $4.2B | $5B | $5B | $4.9B | $5.1B | |
| Other Inc / (Exp) | -- | -- | -- | -$284M | -- | |
| Operating Expenses | $4.2B | $5B | $5B | $4.9B | $5.1B | |
| Operating Income | -$1B | $492M | $465M | $535M | $495M | |
| Net Interest Expenses | $181M | $246M | $128M | $104M | $102M | |
| EBT. Incl. Unusual Items | -$1.2B | $246M | $337M | $147M | $393M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$538M | $68M | $92M | $14M | $98M | |
| Net Income to Company | -$690M | $178M | $245M | $134M | $294M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$690M | $178M | $245M | $133M | $295M | |
| Basic EPS (Cont. Ops) | -$4.40 | $1.11 | $1.53 | $0.82 | $1.78 | |
| Diluted EPS (Cont. Ops) | -$4.40 | $1.06 | $1.51 | $0.80 | $1.72 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$205M | $1.3B | $1.3B | $1B | $1.3B | |
| EBIT | -$1B | $493M | $475M | $277M | $520M | |
| Revenue (Reported) | $10.7B | $14.8B | $15.5B | $14.7B | $15B | |
| Operating Income (Reported) | -$1B | $492M | $465M | $535M | $495M | |
| Operating Income (Adjusted) | -$1B | $493M | $475M | $277M | $520M | |
| Period Ending | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | 2026-01-31 | |
|---|---|---|---|---|---|---|
| Revenue | $14.8B | $15.5B | $14.7B | $15B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $9.3B | $10B | $9.3B | $9.4B | -- | |
| Gross Profit | $5.4B | $5.5B | $5.4B | $5.6B | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $5B | $5B | $4.9B | $5.1B | -- | |
| Other Inc / (Exp) | -- | -- | -$284M | -- | -- | |
| Operating Expenses | $5B | $5B | $4.9B | $5.1B | -- | |
| Operating Income | $492M | $465M | $535M | $495M | -- | |
| Net Interest Expenses | $246M | $128M | $104M | $102M | -- | |
| EBT. Incl. Unusual Items | $246M | $337M | $147M | $393M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $68M | $92M | $14M | $98M | -- | |
| Net Income to Company | $178M | $245M | $134M | $294M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $178M | $245M | $133M | $295M | -- | |
| Basic EPS (Cont. Ops) | $1.11 | $1.53 | $0.82 | $1.78 | -- | |
| Diluted EPS (Cont. Ops) | $1.06 | $1.51 | $0.80 | $1.72 | -- | |
| Weighted Average Basic Share | $636M | $640.3M | $647.2M | $657.1M | -- | |
| Weighted Average Diluted Share | $657.1M | $646.8M | $656.7M | $673.1M | -- | |
| EBITDA | $1.3B | $1.3B | $1B | $1.3B | -- | |
| EBIT | $493M | $475M | $277M | $520M | -- | |
| Revenue (Reported) | $14.8B | $15.5B | $14.7B | $15B | -- | |
| Operating Income (Reported) | $492M | $465M | $535M | $495M | -- | |
| Operating Income (Adjusted) | $493M | $475M | $277M | $520M | -- | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $681M | $322M | $687M | $628M | $1B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $245M | $255M | $265M | $334M | $245M | |
| Inventory | $1.9B | $2.3B | $1.9B | $1.9B | $2.1B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $853M | $306M | $316M | $286M | $305M | |
| Total Current Assets | $3.6B | $3.2B | $3.2B | $3.1B | $3.7B | |
| Property Plant And Equipment | $5.3B | $5.1B | $4.8B | $4.5B | $4.5B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $249M | $249M | $249M | $249M | $249M | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $334M | $390M | $466M | $523M | $570M | |
| Total Assets | $9.5B | $8.9B | $8.7B | $8.4B | $9B | |
| Accounts Payable | $2B | $1.5B | $1.2B | $1.2B | $1.3B | |
| Accrued Expenses | $352M | $383M | $291M | $244M | $424M | |
| Current Portion Of Long-Term Debt | $500M | -- | -- | $250M | -- | |
| Current Portion Of Capital Lease Obligations | $260M | $242M | $258M | $240M | $244M | |
| Other Current Liabilities | $1B | $1.2B | $1.2B | $1.1B | $1.1B | |
| Total Current Liabilities | $4.1B | $3.3B | $3B | $3.1B | $3.1B | |
| Long-Term Debt | $2.8B | $2.9B | $2.9B | $2.6B | $2.6B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $9.2B | $8.3B | $8B | $7.6B | $7.8B | |
| Common Stock | $3.2B | $3.3B | $3.4B | $3.4B | $3.5B | |
| Other Common Equity Adj | -$70M | -$50M | -$26M | $8M | $13M | |
| Common Equity | $305M | $581M | $739M | $848M | $1.1B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $305M | $581M | $739M | $848M | $1.1B | |
| Total Liabilities and Equity | $9.5B | $8.9B | $8.7B | $8.4B | $9B | |
| Cash and Short Terms | $681M | $322M | $687M | $628M | $1B | |
| Total Debt | $3.3B | $2.9B | $2.9B | $2.9B | $2.6B | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $681M | $322M | $687M | $628M | $1B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $245M | $255M | $265M | $334M | $245M | |
| Inventory | $1.9B | $2.3B | $1.9B | $1.9B | $2.1B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $853M | $306M | $316M | $286M | $305M | |
| Total Current Assets | $3.6B | $3.2B | $3.2B | $3.1B | $3.7B | |
| Property Plant And Equipment | $5.3B | $5.1B | $4.8B | $4.5B | $4.5B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $249M | $249M | $249M | $249M | $249M | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $334M | $390M | $466M | $523M | $570M | |
| Total Assets | $9.5B | $8.9B | $8.7B | $8.4B | $9B | |
| Accounts Payable | $2B | $1.5B | $1.2B | $1.2B | $1.3B | |
| Accrued Expenses | $352M | $383M | $291M | $244M | $424M | |
| Current Portion Of Long-Term Debt | $500M | -- | -- | $250M | -- | |
| Current Portion Of Capital Lease Obligations | $260M | $242M | $258M | $240M | $244M | |
| Other Current Liabilities | $1B | $1.2B | $1.2B | $1.1B | $1.1B | |
| Total Current Liabilities | $4.1B | $3.3B | $3B | $3.1B | $3.1B | |
| Long-Term Debt | $2.8B | $2.9B | $2.9B | $2.6B | $2.6B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $9.2B | $8.3B | $8B | $7.6B | $7.8B | |
| Common Stock | $3.2B | $3.3B | $3.4B | $3.4B | $3.5B | |
| Other Common Equity Adj | -$70M | -$50M | -$26M | $8M | $13M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $305M | $581M | $739M | $848M | $1.1B | |
| Total Liabilities and Equity | $9.5B | $8.9B | $8.7B | $8.4B | $9B | |
| Cash and Short Terms | $681M | $322M | $687M | $628M | $1B | |
| Total Debt | $3.3B | $2.9B | $2.9B | $2.9B | $2.6B | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$690M | $178M | $245M | $134M | $294M | |
| Depreciation & Amoritzation | $839M | $790M | $789M | $770M | $790M | |
| Stock-Based Compensation | $67M | $79M | $59M | $52M | $72M | |
| Change in Accounts Receivable | -$46M | -- | $23M | -$53M | $78M | |
| Change in Inventories | $53M | -$383M | $265M | -$61M | -$115M | |
| Cash From Operations | -$348M | $705M | $946M | $621M | $1.3B | |
| Capital Expenditures | $385M | $506M | $473M | $569M | $516M | |
| Cash Acquisitions | -- | -- | -- | -$33M | -- | |
| Cash From Investing | -$347M | -$521M | -$393M | -$571M | -$488M | |
| Dividends Paid (Ex Special Dividend) | -$58M | -- | -$119M | -$123M | -$124M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.4B | $1.1B | $100M | -- | -- | |
| Long-Term Debt Repaid | -$800M | -$1.5B | -$100M | -- | -$250M | |
| Repurchase of Common Stock | -- | -- | -$62M | -$1M | -- | |
| Other Financing Activities | -$28M | -$133M | -$34M | -$5M | -$18M | |
| Cash From Financing | $530M | -$544M | -$186M | -$109M | -$372M | |
| Beginning Cash (CF) | $853M | $681M | $322M | $687M | $628M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$165M | -$360M | $367M | -$59M | $407M | |
| Ending Cash (CF) | $681M | $322M | $687M | $628M | $1B | |
| Levered Free Cash Flow | -$733M | $199M | $473M | $52M | $751M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$690M | $178M | $245M | $134M | $294M | |
| Depreciation & Amoritzation | $839M | $790M | $789M | $770M | $790M | |
| Stock-Based Compensation | $67M | $79M | $59M | $52M | $72M | |
| Change in Accounts Receivable | -$46M | -- | -- | -- | -- | |
| Change in Inventories | $53M | -$383M | $265M | -$61M | -$115M | |
| Cash From Operations | -$348M | $705M | $946M | $621M | $1.3B | |
| Capital Expenditures | $385M | $506M | $473M | $569M | $516M | |
| Cash Acquisitions | -- | -- | -- | -$33M | -- | |
| Cash From Investing | -$347M | -$521M | -$393M | -$571M | -$488M | |
| Dividends Paid (Ex Special Dividend) | -$58M | -- | -$119M | -$123M | -$124M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.4B | $1.1B | -- | -- | -- | |
| Long-Term Debt Repaid | -$800M | -$1.5B | -- | -- | -$250M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$28M | -$133M | -$34M | -$5M | -$18M | |
| Cash From Financing | $530M | -$544M | -$186M | -$109M | -$372M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$165M | -$360M | $367M | -$59M | $407M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$733M | $199M | $473M | $52M | $751M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get JWN Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
JWN
Sector
P/E ratio
14.22x
16.11x
PEG ratio
0.12x
0.18x
P/B ratio
3.58x
1.38x
Price / LTM sales
0.27x
0.65x
Growth Metrics
JWN
Sector
Revenue growth
-2.17%
2.11%
Earnings growth
18.29%
--
Revenue (5-year growth)
-0.66%
3.69%
Earnings forecast
$0.93
$0.26
Profitability
JWN
Sector
Profitability FY 2024
$5.6B
$486.3M
Return on invested capital
8.16%
4.87%
Return on assets
3.36%
3.03%
Return on equity
30.99%
7.41%
Earnings Date
Last Earnings Date
Mar
4
Next Earnings Date
May
30
Estimated Next Earnings Date
Jun
3
Balance Sheet
JWN
Sector
Total cash
$1B
$158.4M
Short term investments
--
$52.5M
Total assets
$9B
$1.6B
Long term debt
$2.6B
$157.6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Nu Holdings Stock Be in 2030?
Despite fast growth, high profitability and an extraordinary runway ahead,…
Is it Too Late to Buy United Airlines Stock?
United Airlines (NASDAQ:UAL) has thoroughly outpaced the broader stock market…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 37x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
42
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
52
NUTX alert for Apr 2
Nutex Health [NUTX] is up 5.41% over the past day.
Buy
52
PVH alert for Apr 2
PVH [PVH] is up 1.81% over the past day.
Sell
15
PCVX alert for Apr 2
Vaxcyte [PCVX] is up 4.47% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
